Search - tctmd.com

Displaying 381 - 400 of 851

Sort: Relevancy | Date

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Yael L. Maxwell

March 18, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

Presentation ACC 2019

Primary Results From the Evolut Low Risk Trial

Presenter: Michael J. Reardon

March 17, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

Presentation OPCI 2019

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

Presenter: Gary S. Mintz

March 09, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Manuscript

The Evolution of the Program Coordinator: From One Valve to the Whole Heart

January 07, 2019

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

Presentation Cardiovascular Interventions 2018

DAPT in Evolution: 2018

Presenter: Dean J. Kereiakes

October 26, 2018

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

Presentation TCT Abstracts Posters 2018

Contemporary Evolutionary Analysis of Percutaneous Coronary Intervention in Diabetics

Presenter: Frederico Lopes de Oliveria

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Advertisement

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Primary Results From the Evolut Low Risk Trial

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon Angioplasty to Bioresorbable Scaffolds

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

The Evolution of the Program Coordinator: From One Valve to the Whole Heart

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

DAPT in Evolution: 2018

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Contemporary Evolutionary Analysis of Percutaneous Coronary Intervention in Diabetics

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content